
XORTX Therapeutics Inc.
XRTXHealthcare|Biotechnology|CA
$0.91
+0.00 (+0.00%)
DCF Value
$0.39
Tangible Book / Share
$1.83
Cash / Share
$0.61
Next Earnings Report
Nov 12, 2026
Financing Filings (last 12 months)
2
Shelf registrations / offering prospectuses — latest May 15, 2026 (424B4). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
XORTX Outlines Anticipated Health Canada Clinical Trial Application for XRx-026 for Gout
Oct 8, 2026 · GlobeNewsWire
XORTX Announces Planned FDA IND Submission for XRx-026 Gout Program Using XORLO™, Targeting USD$700M+ U.S. Gout Market Opportunity
Sep 18, 2026 · GlobeNewsWire
XORTX Announces Initiation of Clinical and Commercial Manufacturing of XORLO™
Sep 10, 2026 · GlobeNewsWire
XORTX Re-Engages Investor Relations Program
Sep 8, 2026 · GlobeNewsWire
XORTX Announces Termination and Postponement of Investor Relations Program
Aug 28, 2026 · GlobeNewsWire
SEC Filings (79)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Oct 8, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Sep 18, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Sep 10, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Sep 9, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Sep 4, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Aug 28, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Aug 17, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Aug 4, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jul 29, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jun 15, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jun 12, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| May 19, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| May 19, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| May 15, 2026 | 424B4 | Offering prospectus | DocumentIndex |
| May 14, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| May 13, 2026 | EFFECT | DocumentIndex | |
| May 8, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| May 8, 2026 | POS AM | DocumentIndex | |
| Apr 23, 2026 | POS AM | DocumentIndex | |
| Apr 22, 2026 | POS AM | DocumentIndex | |
| Apr 21, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Apr 16, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Apr 1, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Mar 27, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Mar 27, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Mar 26, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Mar 24, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Mar 20, 2026 | 20-F | Annual report (foreign) | DocumentIndex |
| Mar 19, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Mar 13, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Mar 5, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Mar 3, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Feb 27, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Feb 17, 2026 | EFFECT | DocumentIndex | |
| Feb 13, 2026 | F-1/A | IPO / offering registration | DocumentIndex |
| Feb 5, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jan 2, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Nov 17, 2025 | 6-K | Foreign issuer report | DocumentIndex |
| Oct 31, 2025 | 6-K | Foreign issuer report | DocumentIndex |
| Oct 29, 2025 | 6-K | Foreign issuer report | DocumentIndex |